Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

CDC Compromised by Bias and Conflicts of Interest, Writes Editor of the Journal of American Physicians and Surgeons


TUCSON, Ariz., Sept. 21, 2020 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC), which according to its website is "recognized as the nation's premiere health promotion, prevention and preparedness agency," is playing a leading role in response to the COVID-19 pandemic. In the fall issue of the Journal of American Physicians and Surgeons, editor-in-chief Lawrence R. Huntoon, M.D., Ph.D., analyzes the problems of bias and conflicts of interest highlighted by this crisis.

"The CDC openly admits that it is fudging the COVID-19 death figures," he writes. The statistics have been made to look really scary by adding speculative guesses to the official database. "Those false numbers are sanctioned by the CDC."

Dr. Huntoon notes that the CDC became authorized to accept private gifts in 1983, opening wide the door to corruption and conflicts of interest. Ethics and disclosure requirements are ineffective and non-uniform. A report by the Office of the Inspector General, published in 2010, showed a "systematic lack of oversight" of the ethics program.

"Even when the CDC identifies conflicts of interest for advisory committee members, some allege that the CDC 'automatically' grants annual waivers to the participants. And the CDC's policy on 'prohibited sources' of donations to the CDC Foundation, which allows 'prohibited' donations, makes a complete mockery of the CDC's entire ethics process," he writes.

Industry funding is likely to have influenced agency recommendations concerning viral hepatitis and influenza, to name two examples. Data manipulation has been alleged with respect to the Wise Woman (WW) program as well as studies pertaining to measles mumps rubella (MMR) vaccine and autism, he states.

In 2016 a group of more than a dozen senior scientists at the CDC lodged an ethics complaint alleging that that the CDC was being influenced "by corporate and political interests in ways that shortchange taxpayers." They noted "the pervasive nature of unethical practices throughout all levels at the CDC."

"The CDC has a long history of bias and troubling conflicts of interest. This history calls into question the scientific validity of recommendations made by the CDC," Dr. Huntoon concludes.

The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.

SOURCE Association of American Physicians and Surgeons (AAPS)


These press releases may also interest you

at 08:00
Freedom Financial Holdings , (the "Company" or "Freedom"), the holding company for The Freedom Bank of Virginia (the "Bank") today announced net income of $1,164,226 or $0.16 per diluted share for the first quarter compared to a net loss of...

at 08:00
Virax Biolabs Group Limited ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today the launch of ImmuneSelect ("ImmuneSelect") within the...

at 08:00
Revolve Renewable Power Corp. ("Revolve" or the "Company"), a North American owner, operator and developer of renewable energy projects, is pleased to report that installation works have commenced on the 450kWp rooftop solar...

at 08:00
Carter Bankshares, Inc. (the "Company") , the holding company of Carter Bank & Trust (the "Bank") today announced quarterly net income of $5.8 million, or $0.25 diluted earnings per share ("EPS"), for the first quarter...

at 07:55
United Bankshares, Inc. ("United"), today reported earnings for the first quarter of 2024 of $86.8 million, or $0.64 per diluted share. First quarter of 2024 results produced annualized returns on average assets, average equity and average tangible...

at 07:50
Union Pacific Corporation today reported 2024 first quarter net income of $1.6 billion, or $2.69 per diluted share. This compares to 2023 first quarter net income of $1.6 billion, or $2.67 per diluted share. "Our team delivered strong financial...



News published on and distributed by: